Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 211 entries
Sorted by: Best Match Show Resources per page
[Factors influencing protein loss during peritoneal dialysis].

Polskie Archiwum Medycyny Wewnetrznej

Twardowski Z, Lebek R, Baran H.
PMID: 5543790
Pol Arch Med Wewn. 1971;46(1):69-74.

No abstract available.

Cite
Twardowski Z, Lebek R, Baran H. Czynniki wpływajace na wielkość utraty białka w czasie dializ otrzewnowych. [Factors influencing protein loss during peritoneal dialysis]. Pol Arch Med Wewn. 1971;46(1):69-74
Twardowski, Z., Lebek, R., & Baran, H. (1971). Czynniki wpływajace na wielkość utraty białka w czasie dializ otrzewnowych. [Factors influencing protein loss during peritoneal dialysis]. Polskie Archiwum Medycyny Wewnetrznej, 46(1), 69-74.
Twardowski, Z, et al. "Czynniki wpływajace na wielkość utraty białka w czasie dializ otrzewnowych." [Factors influencing protein loss during peritoneal dialysis]. Polskie Archiwum Medycyny Wewnetrznej vol. 46,1 (1971): 69-74.
Twardowski Z, Lebek R, Baran H. Czynniki wpływajace na wielkość utraty białka w czasie dializ otrzewnowych. [Factors influencing protein loss during peritoneal dialysis]. Pol Arch Med Wewn. 1971;46(1):69-74. Polish. PMID: 5543790.
Copy Download .nbib Format: NLM
Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011-2012: a case-control study.

Infection ecology & epidemiology

Gherasim A, Hjertqvist M, Lundkvist Å, Kühlmann-Berenzon S, Carlson JV, Stenmark S, Widerström M, Österlund A, Boman H, Ahlm C, Wallensten A.
PMID: 26134289
Infect Ecol Epidemiol. 2015 Jun 30;5:27698. doi: 10.3402/iee.v5.27698. eCollection 2015.

INTRODUCTION: Nephropatia epidemica (NE), a relatively mild form of hemorrhagic fever with renal syndrome caused by the Puumala virus (PUUV), is endemic in northern Sweden. We aim to study the risk factors associated with NE in this region.METHODS: We...

Cite
Gherasim A, Hjertqvist M, Lundkvist Å, et al. Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011-2012: a case-control study. Infect Ecol Epidemiol. 2015;5:27698doi: 10.3402/iee.v5.27698.
Gherasim, A., Hjertqvist, M., Lundkvist, �. �., Kühlmann-Berenzon, S., Carlson, J. V., Stenmark, S., Widerström, M., Österlund, A., Boman, H., Ahlm, C., & Wallensten, A. (2015). Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011-2012: a case-control study. Infection ecology & epidemiology, 527698. https://doi.org/10.3402/iee.v5.27698
Gherasim, Alin, et al. "Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011-2012: a case-control study." Infection ecology & epidemiology vol. 5 (2015): 27698. doi: https://doi.org/10.3402/iee.v5.27698
Gherasim A, Hjertqvist M, Lundkvist Å, Kühlmann-Berenzon S, Carlson JV, Stenmark S, Widerström M, Österlund A, Boman H, Ahlm C, Wallensten A. Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011-2012: a case-control study. Infect Ecol Epidemiol. 2015 Jun 30;5:27698. doi: 10.3402/iee.v5.27698. eCollection 2015. PMID: 26134289; PMCID: PMC4488335.
Copy Download .nbib Format: NLM
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans.

Frontiers in physiology

Adiels M, Mardinoglu A, Taskinen MR, Borén J.
PMID: 26635628
Front Physiol. 2015 Nov 20;6:342. doi: 10.3389/fphys.2015.00342. eCollection 2015.

To develop novel strategies for prevention and treatment of dyslipidemia, it is essential to understand the pathophysiology of dyslipoproteinemia in humans. Lipoprotein metabolism is a complex system in which abnormal concentrations of various lipoprotein particles can result from alterations...

Cite
Adiels M, Mardinoglu A, Taskinen MR, et al. Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans. Front Physiol. 2015;6:342doi: 10.3389/fphys.2015.00342.
Adiels, M., Mardinoglu, A., Taskinen, M. R., & Borén, J. (2015). Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans. Frontiers in physiology, 6342. https://doi.org/10.3389/fphys.2015.00342
Adiels, Martin, et al. "Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans." Frontiers in physiology vol. 6 (2015): 342. doi: https://doi.org/10.3389/fphys.2015.00342
Adiels M, Mardinoglu A, Taskinen MR, Borén J. Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans. Front Physiol. 2015 Nov 20;6:342. doi: 10.3389/fphys.2015.00342. eCollection 2015. PMID: 26635628; PMCID: PMC4653309.
Copy Download .nbib Format: NLM
A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice.

Neuropsychiatric disease and treatment

Bodén R, Edman G, Reutfors J, Ostenson CG, Osby U.
PMID: 23682213
Neuropsychiatr Dis Treat. 2013;9:371-7. doi: 10.2147/NDT.S40554. Epub 2013 Mar 19.

It is well known that abdominal obesity, dyslipidemia, and insulin resistance are highly prevalent in patients receiving maintenance treatment with antipsychotics, but there is limited knowledge about the association between cardiovascular risk factors and treatment with antipsychotic drugs. In...

Cite
Bodén R, Edman G, Reutfors J, et al. A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice. Neuropsychiatr Dis Treat. 2013;9:371-7doi: 10.2147/NDT.S40554.
Bodén, R., Edman, G., Reutfors, J., Ostenson, C. G., & Osby, U. (2013). A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice. Neuropsychiatric disease and treatment, 9371-7. https://doi.org/10.2147/NDT.S40554
Bodén, Robert, et al. "A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice." Neuropsychiatric disease and treatment vol. 9 (2013): 371-7. doi: https://doi.org/10.2147/NDT.S40554
Bodén R, Edman G, Reutfors J, Ostenson CG, Osby U. A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice. Neuropsychiatr Dis Treat. 2013;9:371-7. doi: 10.2147/NDT.S40554. Epub 2013 Mar 19. PMID: 23682213; PMCID: PMC3653763.
Copy Download .nbib Format: NLM
Retracted: 147 reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes. A link between lipid storage and insulin resistance.

Atherosclerosis. Supplements

Andersson L, Myhre S, Bostrom P, Ståhlman M, Vind B, Håversen L, Borén J, Hojlund K, Olofsson SO.
PMID: 25604053
Atheroscler Suppl. 2011 Jun;12(1):33-4. doi: 10.1016/S1567-5688(11)70148-9. Epub 2011 Jul 23.

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This abstract has been retracted at the request of Jan Borén, co-author, because of conscious fabrication, corruption or suppression of basic material and conscious preparation and...

Cite
Andersson L, Myhre S, Bostrom P, et al. Retracted: 147 reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes. A link between lipid storage and insulin resistance. Atheroscler Suppl. 2011;12(1):33-4doi: 10.1016/S1567-5688(11)70148-9.
Andersson, L., Myhre, S., Bostrom, P., Ståhlman, M., Vind, B., Håversen, L., Borén, J., Hojlund, K., & Olofsson, S. O. (2011). Retracted: 147 reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes. A link between lipid storage and insulin resistance. Atherosclerosis. Supplements, 12(1), 33-4. https://doi.org/10.1016/S1567-5688(11)70148-9
Andersson, L, et al. "Retracted: 147 reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes. A link between lipid storage and insulin resistance." Atherosclerosis. Supplements vol. 12,1 (2011): 33-4. doi: https://doi.org/10.1016/S1567-5688(11)70148-9
Andersson L, Myhre S, Bostrom P, Ståhlman M, Vind B, Håversen L, Borén J, Hojlund K, Olofsson SO. Retracted: 147 reduced syntaxin-5 in skeletal muscle of patients with type 2 diabetes. A link between lipid storage and insulin resistance. Atheroscler Suppl. 2011 Jun;12(1):33-4. doi: 10.1016/S1567-5688(11)70148-9. Epub 2011 Jul 23. PMID: 25604053.
Copy Download .nbib Format: NLM
Fractionation of halogenated organic matter present in rain and snow.

Chemosphere

Laniewski K, Boren H, Grimvall A.
PMID: 10901663
Chemosphere. 1999 Jan;38(2):393-409. doi: 10.1016/s0045-6535(98)00181-7.

Organic matter in samples of rain and snow from Sweden, Poland, Germany and the Republic of Ireland was fractionated by employing a series of filtration, purging, evaporation and extraction steps. Determinations of the group parameter AOX (adsorbable organic halogens)...

Cite
Laniewski K, Boren H, Grimvall A. Fractionation of halogenated organic matter present in rain and snow. Chemosphere. 1999;38(2):393-409doi: 10.1016/s0045-6535(98)00181-7.
Laniewski, K., Boren, H., & Grimvall, A. (1999). Fractionation of halogenated organic matter present in rain and snow. Chemosphere, 38(2), 393-409. https://doi.org/10.1016/s0045-6535(98)00181-7
Laniewski, et al. "Fractionation of halogenated organic matter present in rain and snow." Chemosphere vol. 38,2 (1999): 393-409. doi: https://doi.org/10.1016/s0045-6535(98)00181-7
Laniewski K, Boren H, Grimvall A. Fractionation of halogenated organic matter present in rain and snow. Chemosphere. 1999 Jan;38(2):393-409. doi: 10.1016/s0045-6535(98)00181-7. PMID: 10901663.
Copy Download .nbib Format: NLM
Development of a harmonized method for the profiling of amphetamines. I. Synthesis of standards and compilation of analytical data.

Forensic science international

Aalberg L, Andersson K, Bertler C, Borén H, Cole MD, Dahlén J, Finnon Y, Huizer H, Jalava K, Kaa E, Lock E, Lopes A, Poortman-van der Meer A, Sippola E.
PMID: 15749364
Forensic Sci Int. 2005 May 10;149(2):219-29. doi: 10.1016/j.forsciint.2004.06.020.

Reference material was synthesised for 21 substances that are frequently present as synthetic impurities, i.e. by-products, in illicitly produced amphetamine. Each of these substances is a typical by-product for at least one of the three approaches most often used...

Cite
Aalberg L, Andersson K, Bertler C, et al. Development of a harmonized method for the profiling of amphetamines. I. Synthesis of standards and compilation of analytical data. Forensic Sci Int. 2005;149(2):219-29doi: 10.1016/j.forsciint.2004.06.020.
Aalberg, L., Andersson, K., Bertler, C., Borén, H., Cole, M. D., Dahlén, J., Finnon, Y., Huizer, H., Jalava, K., Kaa, E., Lock, E., Lopes, A., Poortman-van der Meer, A., & Sippola, E. (2005). Development of a harmonized method for the profiling of amphetamines. I. Synthesis of standards and compilation of analytical data. Forensic science international, 149(2), 219-29. https://doi.org/10.1016/j.forsciint.2004.06.020
Aalberg, Laura, et al. "Development of a harmonized method for the profiling of amphetamines. I. Synthesis of standards and compilation of analytical data." Forensic science international vol. 149,2 (2005): 219-29. doi: https://doi.org/10.1016/j.forsciint.2004.06.020
Aalberg L, Andersson K, Bertler C, Borén H, Cole MD, Dahlén J, Finnon Y, Huizer H, Jalava K, Kaa E, Lock E, Lopes A, Poortman-van der Meer A, Sippola E. Development of a harmonized method for the profiling of amphetamines. I. Synthesis of standards and compilation of analytical data. Forensic Sci Int. 2005 May 10;149(2):219-29. doi: 10.1016/j.forsciint.2004.06.020. PMID: 15749364.
Copy Download .nbib Format: NLM
Dioxazaborocanes: old adducts, new tricks.

Organic & biomolecular chemistry

Bonin H, Delacroix T, Gras E.
PMID: 21537514
Org Biomol Chem. 2011 Jul 07;9(13):4714-24. doi: 10.1039/c1ob05330b. Epub 2011 May 03.

Dioxazaborocanes are boronic adducts obtained by condensation of diethanolamine derivatives with boronic compounds. They were first described in the mid-1950's as a practical way to isolate a boronic adduct. Their use has for a long time been restricted to...

Cite
Bonin H, Delacroix T, Gras E. Dioxazaborocanes: old adducts, new tricks. Org Biomol Chem. 2011;9(13):4714-24doi: 10.1039/c1ob05330b.
Bonin, H., Delacroix, T., & Gras, E. (2011). Dioxazaborocanes: old adducts, new tricks. Organic & biomolecular chemistry, 9(13), 4714-24. https://doi.org/10.1039/c1ob05330b
Bonin, Hélène, et al. "Dioxazaborocanes: old adducts, new tricks." Organic & biomolecular chemistry vol. 9,13 (2011): 4714-24. doi: https://doi.org/10.1039/c1ob05330b
Bonin H, Delacroix T, Gras E. Dioxazaborocanes: old adducts, new tricks. Org Biomol Chem. 2011 Jul 07;9(13):4714-24. doi: 10.1039/c1ob05330b. Epub 2011 May 03. PMID: 21537514.
Copy Download .nbib Format: NLM
Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients.

International journal of tryptophan research : IJTR

Baran H, Hainfellner JA, Kepplinger B.
PMID: 23300346
Int J Tryptophan Res. 2012;5:49-64. doi: 10.4137/IJTR.S10627. Epub 2012 Dec 13.

Kynurenic acid, an intermediate metabolite of L-kynurenine, is a competitive antagonist of inotropic excitatory amino acid (EAA) receptors as well as a non competitive antagonist of 7 alpha nicotine cholinergic receptors and its involvement in memory deficit and cognition...

Cite
Baran H, Hainfellner JA, Kepplinger B. Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients. Int J Tryptophan Res. 2012;5:49-64doi: 10.4137/IJTR.S10627.
Baran, H., Hainfellner, J. A., & Kepplinger, B. (2012). Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients. International journal of tryptophan research : IJTR, 549-64. https://doi.org/10.4137/IJTR.S10627
Baran, H, et al. "Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients." International journal of tryptophan research : IJTR vol. 5 (2012): 49-64. doi: https://doi.org/10.4137/IJTR.S10627
Baran H, Hainfellner JA, Kepplinger B. Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients. Int J Tryptophan Res. 2012;5:49-64. doi: 10.4137/IJTR.S10627. Epub 2012 Dec 13. PMID: 23300346; PMCID: PMC3528109.
Copy Download .nbib Format: NLM
Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma.

Non-coding RNA

Bonen H, Kol N, Shomron N, Leibowitz-Amit R, Quagliata L, Lorber T, Sidi Y, Avni D.
PMID: 29657265
Noncoding RNA. 2016 Jun 30;2(3). doi: 10.3390/ncrna2030007.

The threshold of 200 nucleotides (nt) conventionally divides non-coding RNAs (ncRNA) into long ncRNA (lincRNA, that have more than 200 nt in length) and the remaining ones which are grouped as "small" RNAs (microRNAs, small nucleolar RNAs and piwiRNAs)....

Cite
Bonen H, Kol N, Shomron N, et al. Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma. Noncoding RNA. 2016;2(3)doi: 10.3390/ncrna2030007.
Bonen, H., Kol, N., Shomron, N., Leibowitz-Amit, R., Quagliata, L., Lorber, T., Sidi, Y., & Avni, D. (2016). Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma. Non-coding RNA, 2(3), . https://doi.org/10.3390/ncrna2030007
Bonen, Hamutal, et al. "Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma." Non-coding RNA vol. 2,3 (2016). doi: https://doi.org/10.3390/ncrna2030007
Bonen H, Kol N, Shomron N, Leibowitz-Amit R, Quagliata L, Lorber T, Sidi Y, Avni D. Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma. Noncoding RNA. 2016 Jun 30;2(3). doi: 10.3390/ncrna2030007. PMID: 29657265; PMCID: PMC5831909.
Copy Download .nbib Format: NLM
Correction: Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition.

PLoS genetics

Svensk E, Devkota R, Ståhlman M, Ranji P, Rauthan M, Magnusson F, Hammarsten S, Johansson M, Borén J, Pilon M.
PMID: 27257966
PLoS Genet. 2016 Jun 03;12(6):e1006112. doi: 10.1371/journal.pgen.1006112. eCollection 2016 Jun.

[This corrects the article DOI: 10.1371/journal.pgen.1005982.].

Cite
Svensk E, Devkota R, Ståhlman M, et al. Correction: Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition. PLoS Genet. 2016;12(6):e1006112doi: 10.1371/journal.pgen.1006112.
Svensk, E., Devkota, R., Ståhlman, M., Ranji, P., Rauthan, M., Magnusson, F., Hammarsten, S., Johansson, M., Borén, J., & Pilon, M. (2016). Correction: Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition. PLoS genetics, 12(6), e1006112. https://doi.org/10.1371/journal.pgen.1006112
Svensk, Emma, et al. "Correction: Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition." PLoS genetics vol. 12,6 (2016): e1006112. doi: https://doi.org/10.1371/journal.pgen.1006112
Svensk E, Devkota R, Ståhlman M, Ranji P, Rauthan M, Magnusson F, Hammarsten S, Johansson M, Borén J, Pilon M. Correction: Caenorhabditis elegans PAQR-2 and IGLR-2 Protect against Glucose Toxicity by Modulating Membrane Lipid Composition. PLoS Genet. 2016 Jun 03;12(6):e1006112. doi: 10.1371/journal.pgen.1006112. eCollection 2016 Jun. PMID: 27257966; PMCID: PMC4892886.
Copy Download .nbib Format: NLM
Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus.

Neuro-Signals

Kepplinger B, Baran H, Kronsteiner C, Reuss J.
PMID: 31059212
Neurosignals. 2019;27(1):1-11. doi: 10.33594/000000095.

BACKGROUND/AIMS: Normal pressure hydrocephalus (NPH) is a potentially reversible neurological syndrome commonly characterized by gait disturbance, urinary incontinence, and dementia. Hydrocephalus e-vacuo (He-v) is also characterized by the occurrence of dementia but does not show gait disturbance or urinary...

Cite
Kepplinger B, Baran H, Kronsteiner C, et al. Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus. Neurosignals. 2019;27(1):1-11doi: 10.33594/000000095.
Kepplinger, B., Baran, H., Kronsteiner, C., & Reuss, J. (2019). Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus. Neuro-Signals, 27(1), 1-11. https://doi.org/10.33594/000000095
Kepplinger, Berthold, et al. "Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus." Neuro-Signals vol. 27,1 (2019): 1-11. doi: https://doi.org/10.33594/000000095
Kepplinger B, Baran H, Kronsteiner C, Reuss J. Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus. Neurosignals. 2019;27(1):1-11. doi: 10.33594/000000095. PMID: 31059212.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 211 entries